For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...
A novel regimen of doravirine and islatravir was noninferior to a common HIV therapy as an initial HIV treatment, according ...
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...
Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.
A wave of under-the-radar HIV policy changes is unfolding nationwide, with advocates warning of serious, far-reaching consequences.
The Federal Government has announced the introduction of Lenacapavir, a long-acting injectable drug for the prevention of ...
The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients lose medication assistance.
New Jersey's AIDS Drug Assistance Program helps thousands of residents access crucial HIV medications, but funding cuts might lead to tighter eligibility, raising worries about public health and ...
Thousands of low-income people living with HIV could be losing drug coverage as states impose limitations on HIV assistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results